Cargando…
Enhancing T cell therapy through TCR signaling-responsive nanoparticle drug delivery
Adoptive cell therapy (ACT) with antigen-specific T cells has shown remarkable clinical success, but approaches to safely and effectively augment T cell function, especially in solid tumors, remain of great interest. Here we describe a strategy to “backpack” large quantities of supporting protein dr...
Autores principales: | Tang, Li, Zheng, Yiran, de Melo, Mariane Bandeira, Mabardi, Llian, Castaño, Ana P., Xie, Yu-Qing, Li, Na, Kudchodkar, Sagar B., Wong, Hing C., Jeng, Emily K., Maus, Marcela V., Irvine, Darrell J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078803/ https://www.ncbi.nlm.nih.gov/pubmed/29985479 http://dx.doi.org/10.1038/nbt.4181 |
Ejemplares similares
-
T lymphocyte engineering with cytokine nanogels for enhanced cancer immunotherapy
por: Tang, Li, et al.
Publicado: (2015) -
IgG-Engineered Protective Antigen for Cytosolic Delivery
of Proteins into Cancer Cells
por: Lu, Zeyu, et al.
Publicado: (2021) -
Optimization of storage conditions for lipid nanoparticle-formulated self-replicating RNA vaccines
por: Kim, Byungji, et al.
Publicado: (2023) -
Enhancing Humoral Responses Against HIV Envelope Trimers via Nanoparticle Delivery with Stabilized Synthetic Liposomes
por: Tokatlian, Talar, et al.
Publicado: (2018) -
T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity
por: Schmid, Daniela, et al.
Publicado: (2017)